Microaspiration in Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Idiopathic Pulmonary Fibrosis
Related studies linked through entity extraction aliases.
Safety and PK Study of BIBF 1120 in Japanese Patients With IPF
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)
- Status
- COMPLETED
- Phase
- N/A
Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) Patients
- Status
- COMPLETED
- Phase
- NA
Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study
- Status
- COMPLETED
- Phase
- N/A
Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- N/A
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)
- Status
- UNKNOWN
- Phase
- N/A
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- N/A
Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
- Status
- TERMINATED
- Phase
- PHASE3
Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study
- Status
- COMPLETED
- Phase
- PHASE2
ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
- Status
- TERMINATED
- Phase
- PHASE3
Idiopathic Pulmonary Fibrosis Registry for Future Studies
- Status
- COMPLETED
- Phase
- N/A
(ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF
- Status
- TERMINATED
- Phase
- PHASE3
Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
- Status
- TERMINATED
- Phase
- PHASE2
Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- NA
Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE3
Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study
- Status
- UNKNOWN
- Phase
- PHASE4
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
- Status
- COMPLETED
- Phase
- PHASE3